The most outstanding
Grupo SURA ended the year 2025 with a recurring net income of COP 2.3 trillion
Publicado el 27 February 2026
Grupo SURA marks 15 years in the S&P Global Sustainability Yearbook
Publicado el 19 February 2026
Notice of the Upcoming Ordinary Annual Shareholders' Meeting - 2026
Publicado el 18 February 2026
News Center
Colombia signs an agreement governing the co -development of vaccines using mRNA technology
Publicado el 16 December 2021
A New Subsidiary
Publicado el 15 December 2021
Reminder of the upcoming extraordinary meeting of the general assembly of shareholders
Publicado el 06 December 2021